Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0404-9887

6 FDA label images from Henry Schein, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0404-9887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of Lidocaine Hydrochloride Anhydrous showing the molecular arrangement including aromatic ring, amide group, and hydrochloride and water components.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
A data table showing different concentrations of Lidocaine Hydrochloride (anhydrous) injection solutions. Concentrations include 0.5%, 1%, 1.5%, and 2%, with corresponding mg/mL amounts of lidocaine HCl (5 to 20 mg/mL) and sodium chloride (6 to 8 mg/mL) listed for each concentration.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
A table showing recommended dosages of Lidocaine Hydrochloride Injection, USP, without epinephrine, for various anesthetic procedures in normal healthy adults. It lists procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, detailing concentration, volume, and total dose ranges for each.*
FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
A data table listing various unit sales, concentrations, and packaging forms of Lidocaine Hydrochloride injection solutions. The table includes multiple single-dose options with varying concentrations from 0.5% to 2%, different packaging sizes such as trays, cases, and cartons, and packaging types including glass teartop vials and glass ampuls, each accompanied by specific NDC codes.*
FDA Label Image

Image5.jpg (Image5)

Image5.jpg (Image5)
Table presenting unit of sale, concentration, container type, and NDC codes for Lidocaine Hydrochloride Injection, Solution. It details single-dose and multiple-dose packaging options, including clam cells, ampuls, and plastic fliptop vials, with concentrations ranging from 0.5% to 2% (5 mg/mL to 20 mg/mL).*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Label for Lidocaine Hydrochloride Injection USP, single dose ampule containing 10 mg/mL strength. The label indicates it is for infiltration and nerve block including epidural and caudal, preservative-free. Packaged by Henry Schein, Inc. with storage instructions at controlled room temperature 59°F to 77°F. Includes barcode, lot, expiration placeholders, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.